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1. Introduction 
Several compounds with tensioactive properties are synthesized by living organisms, from 
plants (e.g. saponins) to microorganisms (e.g. glycolipids) and humans (e.g. surface-active 
lipoprotein complex), being considered natural surfactants [1]. Additionally, these 
compounds have been produced through biotechnological processes broadening their 
diversity and potential applications [2]. Surfactants are usually organic compounds that are 
amphiphilic, meaning they contain both hydrophobic groups (tails) and hydrophilic groups 
(heads), and that act preferably in the interface of fluid phases with different levels of 
polarity and bridges of hydrogen, such as oil/water or air/water interfaces. Many microbes 
appear to produce a complex mixture of biosurfactants, particularly during their stationary 
growth on water-immiscible substrates. Generally, biosurfactants are secondary metabolites 
with the typical amphiphilic structure of a surfactant, where the hydrophobic moiety is 
either a long-chain fatty-acid, hydroxyl fatty acid, or -alkyl--hydroxy fatty acid and the 
hydrophilic moiety can be a carbohydrate, an amino acid, a cyclic peptide, a phosphate, a 
carboxylic acid, or alcohol, among others [1].  
Physical and chemical properties, surface tension reduction, and stability of the emulsion 
formed are important characteristics in biosurfactant that make possible its use in countless 
biological applications. Most work on biosurfactant applications has been focused on their 
use in environmental applications owing to their diversity, environmentally friendly nature, 
suitability for large-scale production and selectivity [3]. Biosurfactants have several 
advantages over chemical surfactants, such as lower toxicity, higher biodegradability and 
effectiveness at extreme temperatures or pH values [4]. Many of the potential applications 
that have been considered for biosurfactants depend on whether they can be produced 
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economically; however, much effort in process optimization and at the engineering and 
biological levels have been carried out [5]. Despite their potential and biological origin only 
a few studies have been carried out on applications related to the biomedical field [6]. Some 
biosurfactants are suitable alternatives to synthetic medicines and antimicrobial agents and 
may be used as safe and effective therapeutic agents [6]. 
Furthermore, biosurfactants have been found to inhibit the adhesion of pathogenic 
organisms to solid surfaces or to infection sites hampering biofilm formation that is the 
cause of many diseases, as for example cystic fibrosis [7]. Therefore, prior adhesion of 
biosurfactants to solid surfaces might constitute a new and effective means of combating 
colonization by pathogenic microorganisms and subsequent biofilm formation [8,9].  
Pre-coating vinyl urethral catheters by running a surfactin solution through them before 
inoculation with media resulted in a decrease in the amount of biofilm formed by 
Salmonella typhimurium, S. enterica, Escherichia coli and Proteus mirabilis [10]. Given the 
importance of opportunistic infections with Salmonella species, including urinary tract 
infections of AIDS patients, these results have great potential for practical applications. In 
addition, the use of lactobacilli as a probiotic for the prevention of urogenital infections has 
been widely studied [11].  
Microbial surfactants are not yet competitive with those produced by the chemical industry, 
but efforts should be made on the different production aspects to find suitable and economic 
substrates and to develop new strategies to increase the volumetric productivity. We have 
shown that the co-utilization of ground-nut oil refinery residue and corn steep liquor is an 
attractive choice for biosurfactant production. The biosurfactant adhesive mechanism is 
based in the inhibition of microorganisms to different surfaces can interact with interfaces of 
the molecule. In this sense, they are an alternative to synthetic surface-active agents because 
of their low toxicity and biodegradability [7,12]. 
Considering the lack of studies with yeasts biosurfactants for medical purposes, and is an 
attractive characteristics showed by produced by the Candida lipolytica (Rufisan) and Candida 
sphaerica (Lunasan). In this sense the revision shown the role and applications of rufisan and 
lunasan biosurfactant as a antimicrobial and antiadhesive activities were investigated 
against pathogenic and nonpathogenic microorganisms, and indicated the therapeutic 
perspectives.. Results gathered in the current work showed the potential of those molecules 
in this field of application; however, its use still remains limited, possibly as due to high 
production costs, as well as on their toxicity towards human systems.  
2. Adhesion and microbial biofilms 
The interest of biosurfactants as alternative medicines and antimicrobial agents increased 
considering the safe use as effective therapeutic agent on human and animal cells [12]. In 
consequence, the microbial adhesion is mediated by specific interactions between cells surface 
structures and molecular mass on the substratum surface, or by non-specific interaction forces, 
including electrostatic forces, acid-base interactions and Vander Waals forces [13].  
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during exponential growth, presumably as a result of increased cell wall hydrophobicity 
during this growth phase 
The conditioning film on the biomaterial surface (and on the bacterial cell surface) plays an 
important role, as it changes the physicochemical properties of the interacting surfaces. 
Albumin is a strong adhesion inhibitor, for unknown reasons, although changes in 
hydrophobiciy and sterical hindrance are proposed as mechanisms [14]. 
The adhesion of microorganisms to a surface is one of the first stages in the development of 
a biofilm and is believed to be influenced by a number of factors. As the substrate is 
essential in the development of a biofilm, an understanding of how substrate properties 
affected the adherence of bacterial cells my assist in designing or modifying substrates 
inhibitory to bacterial adhesion. Many of these molecules are proteinaceous constitution, 
such as serum albumin, fibrogen and collagen, and some have been shown to affect 
subsequent bacterial adhesion [13]. 
The formation of infectious biofilm on biomaterial appeared to involve several sequential 
steps. Immediately after exposure of a device to body fluids, such as blood, saliva, or urine, 
macromolecular components adsorb to form a conditioning film [15]. The most microbial 
surfactants are complex molecules, comprising different structures that include peptides, 
glycolipids, glycopeptides, fatty acids and phospolipids, as reviewed recently. Among the 
many classes of biosurfactants, lipopeptides are particularly interesting because their high 
surface activities and antibiotic potential. Lipopeptides are molecules act as antibiotics, 
antiviral and antitumoral agents, and enzyme inhibitors. Those molecules enhance or 
decrease the bacterial surface hydrophobicity following that the surface is less or more 
hydrophobic[16]. Morikawa et al. [17] identified and characterized a biosurfactant, 
arthrofactin, produced by Arthrobacter. 
Glycolipids are the most common class of biosurfactans of which the most effective from the 
point of view of surface active properties arethe trehalose lipids of Mycobacterium and 
related bacteria, the rhamnolipids of Pseudomonas sp and the sophorolipids of yeasts [18]. 
Otto et al. [19] described the production of sophorose lipids from deproteinized whey 
concentrate by a two-stage process. Several antimicrobial, immunological and neurological 
properties have been attributed to mannosylerythritol lipid (MEL), a yeast glycolipid 
biosurfactant, produced from vegetable oils by Candida strains. 
3. Antimicrobial activity of biosurfactant 
Several biosurfactants which exhibit antimicrobial activity against various microorganisms 
have been previously described. They include surfactin and iturin produced by Bacillus 
subtilis strains [20], rhamnolipids from Pseudomonas species [21], mannosylerythritol lipids 
from C. antarctica [22] and biosurfactants produced by some fungi [23]. 
Among the genus Bacillus, B. subtilis produces a broad spectrum of bioactive lipopeptides 
which have a great potential for biotechnological and biopharmaceutical applications. The 
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characteristic structure of lipopeptides is a fatty acid combined with an amino-acid moiety. 
Several lipopeptides have potent antibiotic activity and have been the subject of several 
studies on the discovery of new antibiotics. The list includes surfactin, produced by B. 
subtilis, the most powerful of biosurfactant known to date. These compounds have many 
pharmacological activities: antibacterial, antifungal, antiviral, and antimycoplasma 
properties; inhibition of the fibrin clot formation and hemolysis; formation of ion channels 
in lipid bilayer membranes [24]; antitumour activity against Ehrlich’s ascites carcinoma cells; 
and inhibition of the cyclic adenosine 3,5-monophosphate phosphodiesterase [25]. 
The evaluation of the antimicrobial activity of these compounds was carried out against 29 
bacteria. Enterococcus faecalis (11 strains), Staphylococcus aureus (6 strains) and Pseudomonas 
aeruginosa (7 strains) and Escherichia coli CI 18 (1 strain) displayed a profile of well defined 
drug resistance. All strains were sensitive to the surfactants, in particular Enterococcus faecalis. 
The results demonstrated that lipopeptides have a broad spectrum ofaction, including 
antimicrobial activity against microorganisms with multidrug-resistant profiles [26]. 
The antimicrobial activity of the crude biosurfactant isolated from Candida lipolytica UCP 
0988 was determined by measuring the growth inhibition percentages obtained for several 
microorganisms (Table 1). 
 
Table 1. Percentages of growth inhibition obtained with the biosurfactant Rufisan isolated from 
Candida lipolytica at different concentrations (mg/l). Results are expressed as means ± standard 
deviations of values obtained from triplicate experiments 
The biosurfactant was effective against the microorganisms tested, albeit to different 
degrees. The highest anti-adhesive percentages were obtained for a biosurfactant 
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concentration of 12 mg/l or 4xCMC. Non-pathogenic species associated with the oral cavity 
of Streptococcus were used (S. mutans HG – 64.9%; S. oralis J22 – 62.8%; S. mutans – 58%; S. 
sanguis 12 – 48%; S. mutans NS – 46%). On the other hand, the biosurfactant did not show an 
effective antimicrobial activity against the Lactobacillus strains studied. It inhibited only 
32.1% of the growth of L. reuteri ML1 at the maximum concentration tested (12 mg/l). 
The growth of the other microorganisms tested was poorly inhibited. Percentages of 5%, 5%, 
15%, 16% and 18% were observed for C. albicans, E. coli, S. aureus, P. aeruginosa and S. 
epidermidis, respectively. 
The antimicrobial activity of the biosurfactant isolated from Candida sphaerica was 
determined by measuring the growth inhibition percentages obtained for several 
microorganisms (Table 2).  
 
Table 2. Percentages of growth inhibition obtained with the crude biosurfactant Lunasan isolated from 
Candida sphaerica at different concentrations (mg/l). Results are expressed as means ± standard 
deviations of values obtained from triplicate experiments 
The tested biosurfactant presented antimicrobial activity against all microorganisms used, 
although, depending on the microorganism, the biosurfactant presents different effective 
concentrations. The highest concentration of biosurfactant tested (10 mg ml-1) showed high 
percentages of inhibition for Streptococcus oralis J22 (68%), C. albicans (57%) and 
Staphylococcus epidermidis (57.6%). The antimicrobial activity of the crude biosurfactant 
isolated from Candida sphaerica with concentrations between 5 and 10 mg ml1 against C. 
albicans, Staph. aureus and Staph. epidermidis was less to that obtained with the biosurfactants 
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isolated from Lact. paracasei ssp A20, which completely inhibited the growth of those 
microrganisms with concentrations between 25 and 50 mg ml-1) [27] . 
The crude biosurfactant showed antimicrobial activity against a broad range of micro-
organisms, including Gram-positive and Gram-negative bacteria and yeasts.  
Biosurfactants antimicrobial activity has been described, as for example surfactin, a cyclic 
lipopeptide produced by Bacillus subtilis [28]. The antimicrobial activity of surfactin was 
tested against several microbes. All tested bacteria, except for B. subtilis, showed 
susceptibility to surfactin. P. aeruginosa was the most sensitive Gram-negative bacteria, 
while E. coli, Salmonella choterasius and Serratia marcescens were inhibited in a lower level. 
Also, the lipopeptide affected the growth of Gram-positive bacteria, especially Micrococcus 
luteus and Bacillus cereus [18]. Other examples have been reported by Rodrigues and co-
workers [8, 27]. Crude biosurfactants isolated from Lactococcus lactis 53 and Streptococcus 
thermophilus A showed antimicrobial activity against C. troplicalis GB in low 
concentrations. 
Some biosurfactants are able, even in low concentrations, to destabilize the microorganism’s 
membranes, killing them or disabling their growth [29, 30]. The interest in biosurfactants 
was first expressed due to its potential antimicrobial properties, being the first reported and 
actually the most studied biosurfactants, rhamnolipid and surfactin [31]. Gram-positive 
bacteria are more sensitive to biosurfactants than Gram-negative bacteria, which are weakly 
inhibited or not inhibited at all [32]. C. bombicola and C. apicola were reported to produce a 
glycolipid-type biosurfactant (sophorolipid) that inhibit the growth of B. subtilis, S. 
epidermidis and Streptococcus faecium in concentrations between 6 and 29 mg/l [33]. Other 
glycolipids inhibit not only the growth of Gram-positive bacteria, but also Gram-negative 
ones, such as E. coli and S. marcescens [31]. Kitamoto et al. [34] reported in their work an 
antimicrobial activity against S. aureus, E. coli, P. aeruginosa and C. albicans for a 
mannosylerythritol roduced by C. antarctica, a sophorolipid produced by C. apicola and a 
rhamnolipid produced by P. aeruginosa.  
Several biosurfactants that exhibit antimicrobial activity have been previously described. 
However, there are few reports about the antimicrobial activity of biosurfactants isolated 
from Candida; only biosurfactants obtained from S. thermophilus A and L. lactis 53 showed 
significant antimicrobial activity against several bacterial and yeast strains isolated from 
explanted voice prostheses [35]. 
4. Anti-adhesive activity of biosurfactant 
Involvement of biosurfactants in microbial adhesion and desorption has been widely 
described, and adsorption of biosurfactants to solid surfaces might constitute an effective 
strategy to reduce microbial adhesion and combating colonization by pathogenic 
microorganisms, not only in the biomedical field, but also in other areas, such as the food 
industry [36, 37].  
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Biosurfactants have been found to inhibit the adhesion of pathogenic organisms to solid 
surfacesor to infection sites, thus prior adhesion of biosurfactant to solid surfaces might 
constitute a new and effective means of combating colonization by pathogenic 
microorganisms [12]. Precoating vinyl urethral catheters by running a surfactin solution 
through them before inoculation with media resulted in a decrease of the amount of biofilm 
formed by Salmonella typhimurium, Salmonella enteric, Escherichia coli and Proteus mirabilis [38]. 
Given the importance of opportunistic infections with Salmonella species, including urinary 
tract infections of AIDS patients, these results have great potential for practical applications.  
In addition to the antimicrobial properties, the anti-adhesive activity of the biosurfactant 
was evaluated against a variety of bacterial and fungal strains. The biosurfactant showed 
anti-adhesive activity against most of the microorganisms tested, but the anti-adhesive effect 
depends on the concentration and the micro-organism tested (Table 3). 
 
Table 3. Anti-adhesive properties of crude biosurfactant isolated from Candida lipolytica. Negative 
controls were set at 0% to indicate the absence of biosurfactant. Positive percentages indicate the 
reductions in microbial adhesion when compared to the control. Results are expressed as means ± 
standard deviation of results from triplicate experiments 
The crude biosurfactant showed anti-adhesive activity against most of the microorganisms 
tested from the minimum concentration used (0.75 mg/l). The anti-adhesive property was 
proportional to the concentration of the biosurfactant. For the microorganisms of the 
Lactobacillus anti-adhesive values around 81% were observed at the minor concentration 
tested (0.75 mg/l). The major anti-adhesive specificity was observed against L. casei with 
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values of 91% and 99% with the minimum concentration used. Low inhibitions were 
observed for S. epidermidis and E. coli, with values of 27% and 21%, respectively, at the 
maximum biosurfactant concentration. For the other microorganisms, the anti-adhesive 
activity was above 45%. 
Gudina et al. [24] observed an anti-adhesive activity for the biosurfactant from Lactobacillus 
paracasei against several pathogenic microorganisms such as S. aureus, S. epidermidis and S. 
agalactiae. However, this biosurfactant showed low anti-adhesive activity against E. coli, C. 
albicans and P. aeruginosa, in contrast with the antimicrobial activity exhibited against these 
strains at the same biosurfactant concentrations.  
The use and potential commercial applications of biosurfactants in the medical field has 
increased considerably in the last years. Their antimicrobial and anti-adhesive properties 
make them relevant molecules for use in combating many diseases and infections and as 
therapeutic agents [18].  
 
Table 4. Anti-adhesive properties of crude biosurfactant isolated from Candida sphaerica. Negative 
controls were set at 0% to indicate the absence of biosurfactant. Positive percentages indicate the 
reductions in microbial adhesion when compared to the control 
Adhesion to surfaces and subsequent biofilm formation consist in a surviving strategy used 
by microorganisms in several hostile environments, protecting them from dehydration, 
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predators, biocides and extreme conditions [22]. The antiadhesive activity of this 
biosurfactant was evaluated against a variety of bacterial and fungal strains. The 
biosurfactant showed antiadhesive activity against most of the microrganisms tested, but 
the antiadhesive effect depends on the concentration and the microrganism tested (Table 4). 
This biosurfactant was effective against all the microorganisms tested, albeit to different 
degree. With regard to the Lactobacillus strains, the antiadhesive activity was higher against 
Lact. casei ( 90%), Lact. casei 72 (72%), Lact. reuteri 104R (55%) and Lact. reuteri ML1 (40%). For 
the pathogenic bacteria studied (Streptococcus agalactiae, Streptococcus mutans, Streptococcus 
mutans NS, Streptococcus sanguis 12, Streptococcus salivarius GB and Echerichia coli), a complete 
inhibition of adhesion was also achieved with biosurfactant concentrations of 10 mg ml-1.  
Regarding the yeast, a total inhibition of adhesion was also observed for C. tropicalis GB at a 
biosurfactant concentration of 10 mg ml-1. The highest percentages of adhesion inhibition 
were obtained for P. aeruginosa (92%), Staphylococcus aureus (92%), Streptococcus oralis J22 
(97%) and Rothia dentocariosa GBJ (72%), while low activity was obtained for Streptococcus 
mutans HG 985(50%) and Staphylococcus epidermidis GB(22%).  
The antiadhesive activity of the crude biosurfactant isolated from C. sphaerica completely 
inhibited the adesion with a concentration of 10 mg ml -1 against Streptococcus agalactiae, 
Streptococcus mutans, Streptococcus mutans NS, Streptococcus sanguis 12, Streptococcus salivarius 
GB and Echerichia coli. These results were higher to that obtained with the biosurfactants 
isolated from Lact. paracasei ssp A20 [24]. A role of biosurfactants as defense weapons in 
competition with post-adhesion has been suggested for biosurfactants produced by 
Streptococcus mitis and S. mutans [39].  
Besides possessing antifungal, antibacterial and antiviral activities, biosurfactants have also 
proved to be great inhibitors of microbial adhesion and of biofilm formation. For example, 
the biosurfactant released by S. mitis was found to reduce the adhesion of Streptococcus. 
mutans [40]. Similarly, Lactobacillus fermentum RC-14 releases surfactant compounds that can 
inhibit the adhesion of uropathogenic bacteria, including Enterococcus faecalis.  
The adsorption of a biosurfactant on surface was found to change its hydrophobicity, which 
might caused interference in the adhesion and desorption processes [41]. Furthermore, 
Velraeds et al. [42] reported the inhibition of adhesion of pathogenic enteric bacteria by a 
biosurfactant produced by Lactobacillus fermetum RC-14. The authors suggested the use of this 
anti-adhesive agent in catheters aiming at decreasing biofilm formation. Falagas and Makris 
[37] have proposed the application of biosurfactants isolated from probiotic bacteria to patient 
care equipments (such as catheters and other medical insertional devices) in hospitals, with the 
aim of decreasing colonization by microorganisms responsible for nosocomial infections. 
5. Conclusion 
In conclusion, in this work we have demonstrated the antimicrobial and anti-adhesive 
properties of the crude biosurfactant isolated from C. lipolytica UCP0988 against several 
pathogenic and nonpathogenic microorganisms, including bacteria, yeasts and filamentous 
fungi. The results obtained suggest the possible use of this biosurfactant as an alternative 
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antimicrobial agent in the medical field for applications against microorganisms responsible 
for diseases and infections, making it a suitable alternative to conventional antibiotics. 
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